4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 57 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $29,000 | -99.5% | 3,573 | -99.6% | 0.01% | -99.5% |
| Q2 2022 | $6,014,000 | -77.3% | 861,607 | -50.9% | 2.05% | -47.4% |
| Q1 2022 | $26,543,000 | -19.9% | 1,755,506 | +16.3% | 3.90% | +3.8% |
| Q4 2021 | $33,128,000 | +11.7% | 1,509,944 | +37.3% | 3.76% | -30.3% |
| Q3 2021 | $29,665,000 | +30.3% | 1,099,944 | +16.3% | 5.39% | -8.9% |
| Q2 2021 | $22,765,000 | +74.4% | 945,382 | +214.2% | 5.92% | +150.7% |
| Q1 2021 | $13,052,000 | +1474.4% | 300,886 | +1404.4% | 2.36% | +1271.5% |
| Q4 2020 | $829,000 | – | 20,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 377,777 | $15,659,000 | 5.43% |
| BVF INC/IL | 1,106,070 | $45,847,000 | 1.80% |
| Eagle Health Investments LP | 50,000 | $2,073,000 | 1.33% |
| Ally Bridge Group (NY) LLC | 150,000 | $6,218,000 | 1.07% |
| Casdin Capital, LLC | 780,555 | $32,354,000 | 0.96% |
| VIKING GLOBAL INVESTORS LP | 3,937,914 | $163,227,000 | 0.45% |
| Pinz Capital Management, LP | 19,900 | $825,000 | 0.38% |
| ArrowMark Colorado Holdings LLC | 1,063,744 | $44,092,000 | 0.34% |
| Perceptive Advisors | 600,256 | $24,881,000 | 0.27% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $829,000 | 0.23% |